| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.007 | 1 |